MRD Status Predicts Transplant Benefit in NPM1-Mutated AML MRD Status Predicts Transplant Benefit in NPM1-Mutated AML

MRD-positive patients in first complete remission after induction therapy had a survival benefit after transplant; however, that benefit did not extend to MRD-negative patients after transplant.Medscape Medical News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news